RNA mapping: selection of potent oligonucleotide sequences for antisense experiments.

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Effective antisense sequence identification is critical for accurate protein function studies and therapeutic development.
• Random or gene walking methods often yield low-activity antisense oligonucleotides, complicating research outcomes.
• Potent antisense sequences are essential for reliable inhibition of target proteins in experimental and clinical settings.

Purpose of the Study:

• To highlight the significance of RNA mapping in selecting potent antisense sequences.
• To demonstrate the efficacy of RNA mapping compared to random or gene walking selection methods.
• To present RNA mapping as a reliable and accessible method for antisense sequence discovery.

Main Methods:

• Utilizing RNA mapping to identify accessible sites on target transcripts.
• Designing and testing antisense oligonucleotides targeting mapped sites.
• Quantifying antisense inhibition of protein function (e.g., P-glycoprotein, AT1 receptor binding).

Main Results:

• Antisense oligonucleotides selected via RNA mapping typically achieve >50% inhibition.
• Targeting accessible sites in the 5' region of the multidrug resistance transcript led to potent P-glycoprotein inhibition.
• Oligonucleotides targeting eight sites in the angiotensin type 1 receptor system inhibited binding by at least 50%, with four sites showing >70% inhibition.

Conclusions:

• RNA mapping substantially increases the probability of identifying active antisense sequences.
• This method provides a reliable and straightforward approach for selecting highly potent antisense oligonucleotides.
• RNA mapping is a valuable tool for advancing antisense research and therapeutic applications.